These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14571820)

  • 1. Splenic embolization in a Jehovah's Witness: role of recombinant human factor VIIa.
    Mindikoglu AL; Anantharaju A; George M; Leone N; Bejna J; Van Thiel DH
    Hepatogastroenterology; 2003; 50(53):1697-9. PubMed ID: 14571820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human coagulation factor VIIa in Jehovah's Witness patients undergoing liver transplantation.
    Jabbour N; Gagandeep S; Peilin AC; Boland B; Mateo R; Genyk Y; Selby R; Zeger G
    Am Surg; 2005 Feb; 71(2):175-9. PubMed ID: 16022020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation in Jehovah's witnesses.
    Detry O; Roover AD; Delwaide J; Kaba A; Joris J; Damas P; Lamy M; Honoré P; Meurisse M
    Transpl Int; 2005 Aug; 18(8):929-36. PubMed ID: 16008742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of two cases using fractionated components and factor VIIa.
    Sniecinski RM; Chen EP; Levy JH; Szlam F; Tanaka KA
    Anesth Analg; 2007 Apr; 104(4):763-5. PubMed ID: 17377078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Jehovah's Witness with complex abdominal trauma and coagulopathy: use of factor VII and a review of the literature.
    Haan J; Scalea T
    Am Surg; 2005 May; 71(5):414-5. PubMed ID: 15986972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding in a Jehovah's Witness patient undergoing a redo aortic valve replacement controlled with cryoprecipitate and a prothrombin complex concentrate.
    Robblee JA; Wilkes PR; Dickie SJ; Rubens FD; Bormanis J
    Can J Anaesth; 2012 Mar; 59(3):299-303. PubMed ID: 22161243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of recombinant activated factor VII in a Jehovah's Witness patient.
    Hsieh A; Cheong I
    Am J Emerg Med; 2007 Nov; 25(9):1085.e1-2. PubMed ID: 18022514
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe gastrointestinal haemorrhage responding to recombinant factor VIIa in a Jehovah's Witness with refractory immune thrombocytopenia.
    Virchis A; Hughes C; Berney S
    Hematol J; 2004; 5(3):281-2. PubMed ID: 15167918
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant factor VIIa for major obstetric haemorrhage in a Jehovah's Witness.
    Laird R; Carabine U
    Int J Obstet Anesth; 2008 Apr; 17(2):193-4. PubMed ID: 18308545
    [No Abstract]   [Full Text] [Related]  

  • 10. Treating coagulopathy in liver disease with plasma transfusions or recombinant factor VIIa: an evidence-based review.
    Ramsey G
    Best Pract Res Clin Haematol; 2006; 19(1):113-26. PubMed ID: 16377545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contemporary approach to the care of Jehovah's witnesses.
    Hughes DB; Ullery BW; Barie PS
    J Trauma; 2008 Jul; 65(1):237-47. PubMed ID: 18580506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses.
    Ball AM; Winstead PS
    Pharmacotherapy; 2008 Nov; 28(11):1383-90. PubMed ID: 18956998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic and therapeutic use of recombinant activated factor VII in patients with cirrhosis and coagulation impairment.
    Tsochatzis E; Papatheodoridis GV; Elefsiniotis I; Thanelas S; Theodossiades G; Moulakakis A; Archimandritis AJ
    Dig Liver Dis; 2007 May; 39(5):490-4. PubMed ID: 16787769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven).
    Tanaka KA; Waly AA; Cooper WA; Levy JH
    Anesthesiology; 2003 Jun; 98(6):1513-5. PubMed ID: 12766668
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of recombinant factor viia in a jehovah's witness with auto-immune thrombocytopenia and post-splenectomy haemorrhage.
    Waddington DP; McAuley FT; Hanley JP; Summerfield GP
    Br J Haematol; 2002 Oct; 119(1):286-8. PubMed ID: 12358947
    [No Abstract]   [Full Text] [Related]  

  • 16. Liver transplantation in a Jehovah's witness.
    Detry O; Honoré P; Delwaide J; Dondelinger RF; Meurisse M; Jacquet N
    Lancet; 1999 May; 353(9165):1680. PubMed ID: 10335797
    [No Abstract]   [Full Text] [Related]  

  • 17. Bovine hemoglobin: a nontraditional approach to the management of acute anemia in a Jehovah's Witness patient with autoimmune hemolytic anemia.
    Jordan SD; Alexander E
    J Pharm Pract; 2013 Jun; 26(3):257-60. PubMed ID: 22869910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: a report of four cases.
    Pavese P; Bonadona A; Beaubien J; Labrecque P; Pernod G; Letoublon C; Barnoud D
    Can J Anaesth; 2005 Jan; 52(1):26-9. PubMed ID: 15625252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aortic dissection and hypothermic arrest in a Jehovah's Witness patient: a case for recombinant factor VIIa?
    Ballen J; Raabe M; Muirhead B
    Can J Anaesth; 2006 Apr; 53(4):353-6. PubMed ID: 16575032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postpartum hemorrhage in a Jehovah's Witness patient controlled with Tisseel, tranexamic acid, and recombinant factor VIIa.
    Arab TS; Al-Wazzan AB; Maslow K
    J Obstet Gynaecol Can; 2010 Oct; 32(10):984-7. PubMed ID: 21176309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.